Articles by Reflector - Pharmaceutical Executive


Articles by Reflector

European Clinical Trials: The Die Is Cast

Apr 15, 2014

Politicians and health campaigners are celebrating the final agreement of the EU's new clinical trials rules. But the European drug industry is not so euphoric, writes Reflector.

Whatever Happened To Faster Reimbursement For Generics In Europe?

Apr 1, 2014

The plan to accelerate generic pricing and reimbursement has become another tragic European casualty.

Italian Ruling on Roche and Novartis Resonates Across Europe

Mar 24, 2014

Roche and Novartis have been fined in Italy on pricing conspiracy charges, fueling a wider debate in Europe about expenditure, efficiency and off-label prescribing.

Growing Pains: The European Medicines Agency at 20

Feb 3, 2014

Reflector looks at the growing pains of the European Medicine Agency (EMA) as it faces the key policy challenges of 2014.

Will Europe's Regulatory Watchdog Come Of Age In 2014?

Feb 1, 2014

Reflector looks at the growing pains of the European Medicine Agency (EMA) as it faces key policy challenges of 2014.

Divining the Future of Devices

Oct 1, 2013

European efforts to crack down on safety and pricing issues in the marketing of medical devices may portend long-term problems for Big Pharma.

T-TIPing the Balance in Industry's Favor

Sep 1, 2013

By the start of 2014, industry expects to have a clearer idea of how far the US-EU free trade pact is going.

Pharma Bids for European Funding in New Research Program

Aug 1, 2013

The ?70 billion budget is still subject to final agreement on the European Union's overall spending plans for 2014-2020.

Is National Drug Pricing Freedom in Europe Nearing its Expiry Date?

Apr 1, 2013

The European Union's attempt to update its transparency rules sparks new debate.


Click here